期刊文献+

人胚胎干细胞向内皮祖细胞诱导分化及其应用研究进展 被引量:1

Progress of Differentiating Human Embryonic Stem Cells Into Endothelial Progenitor Cells and Potential Applications
下载PDF
导出
摘要 近年来,内皮细胞的应用价值不断提高,应用领域不断拓宽,但其来源有限,成为研究应用的主要障碍.胚胎干细胞在体外可分化为多种组织细胞系,有可能成为获取内皮细胞的另一来源.就人胚胎干细胞向内皮祖细胞分化、分离方法、相关分子机制及内皮祖细胞应用价值等进行阐述,以期能够引起更多的关注,推动其研究的进展. Endothelial progenitor cells have great prospect for treatment of many diseases.However,derivation of endothelial progenitor cells in vitro is a major restriction for the clinical treatment.Human embryonic stem cells(hESCs) may become an alternative source of endothelial progenitor cells because of their high proliferation capability and in vitro pluripotency.Although,there are many challenges for differentiating hESCs to endothelial progenitor cells in vitro.Current understanding of this subject from recent discoveries in this field was summarized.Future work will be needed to translate these in vitro findings to clinical applications.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2010年第2期138-144,共7页 Progress In Biochemistry and Biophysics
基金 国家高技术研究发展计划(863)领域重大项目(2006AA02A107) 北京市科委科技计划研发攻关类重大项目(D07050701350702)~~
关键词 人胚胎干细胞 内皮祖细胞 分化 应用 human embryonic stem cells endothelial progenitor cells differentiation clinical applications
  • 相关文献

参考文献48

  • 1Wemer N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 2005, 353(10): 999-1005.
  • 2Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Res, 1999, 85(3): 221-228.
  • 3Gehling U M, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95(10): 3106-3112.
  • 4Lin Y, Weisdorf D J, Solovey A, et a/. Origins of circulating endothelial cells and endothelial outgrowth fi'om blood. J Clin Invest, 2000, 105(1): 71-77.
  • 5Drukker M, Katchman H, Katz G, et al.Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells, 2006, 24(2): 221- 229.
  • 6Levenberg S, Golub J S, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA, 2002, 99(7): 4391-4396.
  • 7Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 2004, 21(1): 31-41.
  • 8Li Z, Suzuki Y, Huang M, et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 2008, 26(4): 864-873.
  • 9Kaufman D S, Hanson E T, Lewis R L, et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proe Natl Aead Sei USA, 2001, 98(19): 10716-10721.
  • 10Wang Z Z, Au P, Chen T, et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotech, 2007, 25(3): 317-318.

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部